O'Byrne Jason sold VIR
March 20, 2026 · Form 4 insider transaction
O'Byrne Jason sold 2,500 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$0.00
Total value
N/A
InsiderO'Byrne Jason
RoleOfficer
SecurityCommon Stock
Transaction codeJ: J
Transaction dateMarch 20, 2026
Filing dateMarch 23, 2026
Shares owned after160,115
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transfer without consideration for estate planning purposes.